PreveCeutical Medical Inc.

DB:18H Stock Report

Market Cap: €12.8m

PreveCeutical Medical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Stephen Van Deventer

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.6yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Stephen Van Deventer's remuneration changed compared to PreveCeutical Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$1m

Jun 30 2024n/an/a

-CA$1m

Mar 31 2024n/an/a

-CA$1m

Dec 31 2023n/an/a

-CA$1m

Sep 30 2023n/an/a

-CA$518k

Jun 30 2023n/an/a

-CA$1m

Mar 31 2023n/an/a

-CA$1m

Dec 31 2022n/an/a

-CA$1m

Sep 30 2022n/an/a

-CA$2m

Jun 30 2022n/an/a

-CA$1m

Mar 31 2022n/an/a

-CA$2m

Dec 31 2021CA$123kCA$120k

-CA$2m

Sep 30 2021n/an/a

-CA$3m

Jun 30 2021n/an/a

-CA$2m

Mar 31 2021n/an/a

-CA$4m

Dec 31 2020CA$120kCA$120k

-CA$4m

Sep 30 2020n/an/a

-CA$2m

Jun 30 2020n/an/a

-CA$3m

Mar 31 2020n/an/a

-CA$3m

Dec 31 2019CA$114kCA$111k

-CA$4m

Sep 30 2019n/an/a

-CA$9m

Jun 30 2019n/an/a

-CA$11m

Mar 31 2019n/an/a

-CA$12m

Dec 31 2018CA$173kCA$170k

-CA$12m

Compensation vs Market: Insufficient data to establish whether Stephen's total compensation is reasonable compared to companies of similar size in the German market.

Compensation vs Earnings: Stephen's compensation has increased whilst the company is unprofitable.


CEO

Stephen Van Deventer (55 yo)

7.6yrs

Tenure

CA$123,166

Compensation

Mr. Stephen Van Deventer serves as the Chairman at Preveceutical Medical Inc. and has been its Chief Executive Officer since June 22, 2017, its Director since May 19, 2017 and its Chief Financial Officer s...


Board Members

NamePositionTenureCompensationOwnership
Stephen Van Deventer
Chairman7.7yrsCA$123.17kno data
Makarand Jawadekar
Chief Science Officer7.3yrsCA$75.17kno data
C. Ballantyne
Director1.9yrsno datano data
Ajit S. Shetty
Advisor3.7yrsno datano data
Ruth Henderson
Member of Advisory Boardno datano datano data
Ian Spencer
Member of Advisory Boardno datano datano data
Wanda Halpert
Member of Advisory Boardno datano datano data
Paget Hargreaves
Director of PreveCeutical (Australia) Pty Ltd.6.3yrsno datano data
Aditya Bahl
Advisor & Consultant3.8yrsno datano data
Linnea Olofsson
Director2.6yrsno data0.37%
€ 47.4k
Kathleen Rokita
Director2.3yrsno datano data

3.8yrs

Average Tenure

68.5yo

Average Age

Experienced Board: 18H's board of directors are considered experienced (3.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 12:39
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PreveCeutical Medical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution